EMA

RSS

European Commission grants orphan designation to Vertex's cystic fibrosis candidate

Aug. 18, 2010

EMA validates CTI's expanded pediatric program for pixantrone in NHL

Aug. 16, 2010

Dexamethasone intravitreal implant receives E.U. orphan drug status for noninfectious uveitis

Aug. 16, 2010

MK-4827 receives E.U. orphan drug status in ovarian cancer

Aug. 16, 2010

European Commission grants orphan status to bosutinib in CML

Aug. 13, 2010

Tranilast obtains orphan drug status for prevention of scarring in glaucoma surgery

Aug. 10, 2010

HBGF-1-coated biodegradable device receives E.U. orphan drug status for spinal cord injury

Aug. 10, 2010

EMA grants octenidine orphan drug status for sepsis in premature infants

Aug. 10, 2010

Obeticholic acid receives E.U. orphan drug status for primary biliary cirrhosis

Aug. 10, 2010

Celgene's pomalidomide receives E.U. orphan drug status for myelofibrosis

Aug. 10, 2010